Known For
Recent Appearances
✨
Dave Wallace discusses 16 years covering the off-patent drug industry.
✨
Medicines for Europe legal and annual conferences reviewed.
Anabel Costa-Ferreira
Dave Wallace
✨
Medicines for Europe biosimilars conference discussed market dynamics.
Dave Wallace
Dean Rudge
✨
Katherine Szarama appointed acting CBER director; permanent director search timeline updated.
✨
The future direction and priorities of the generic industry were discussed.